Help us: Donate
Follow us on:
×

Category: Journal club

February 24, 2020
The Journal Club hosted by Dr. Oliver Medvedik, returns on 25th February at 13:00 EST and we are taking a look at a recent paper including researcher Li Huei Tsai who has been investigating the effect of light stimulus on the brain in the context of Alzheimer’s disease. Join us live on our Facebook channel...
February 02, 2020
The January edition of Journal Club, hosted by Dr. Oliver Medvedik, took a look at the results of a recent human trial in which the drug rapamycin was used to treat skin aging with some promising results. (adsbygoogle = window.adsbygoogle || []).push({});
January 24, 2020
The Journal Club will be returning on January 28th at 13:00 EST with your host Dr. Oliver Medvedik. This month we will be taking a look at the results of a recent human trial where the drug rapamycin was used to treat skin aging with some promising results. You can watch the show live on...
December 04, 2019
For the December edition of the Journal Club hosted by Dr. Oliver Medvedik, we are joined by Dr. Matthew O' Connor (Oki) formerly of SENS Research Foundation and now the head researcher at Underdog Pharma, a spun-off biotech company that is developing research conducted at SENS into a hopefully viable solution for heart disease. Dr....
November 29, 2019
For the November episode of the Journal Club, Dr. Oliver Medvedik reviewed a new study from a team of researchers including Professor George Church. The study saw the deployment of a multiple target gene therapy focused on 3 known longevity genes delivered via an adeno-associated virus. The focus was on mitigating T2 diabetes, heart failure, and kidney failure...
November 06, 2019
For the November episode of the Journal Club, Dr. Oliver Medvedik will be reviewing a new study from a team of researchers including Professor George Church. The study saw the deployment of a multiple target gene therapy focused on 3 known longevity genes delivered via an adeno-associated virus. The focus was on mitigating T2 diabetes, heart failure,...